Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"Splicing factor mutations"”.
-
Understanding the mechanistic and functional consequences of splicing factor mutations
RNA splicing is a highly conserved eukaryotic process by which a precursor mRNA is converted into a mature mRNA. Precise regulation of RNA splicing is essential for proper cell development and maintenance. Disruption of RNA splicing is frequently associated with disease. Recent studies identified …
-
Mechanistic consequences of splicing factor mutations and their use for targeted cancer therapy
In 2011 Yoshida et al. identified mutations in RNA splicing factors as some of the most common mutations in patients with myelodysplastic syndrome (MDS). Mutations in splicing machinery result in the dysregulation of hundreds of isoforms, which lead to disease.The dysregulation of these isoforms is …
-
Single-Cell Approaches in Hematologic Cancer Research: Deciphering the lmpact of Splicing Factor Mutations
… se analiza el impacto de las mutaciones en los factores de splicing SF3B1 y U1 en muestras de pacientes de leucemia linfática crónica. En los tumores portadores de la mutación U1 g.3A>C se detectó una firma de expresión única, marcada por una sobreactivación sostenida de la vía NF-κB, así como …
-
An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes
… syndromes (MDS) are common myeloid malignancies. Mutations in splicing factor genes (including SF3B1, SRSF2 and U2AF1) occur in over half of MDS patients and result in aberrant pre-mRNA splicing of many target genes, indicating that aberrant spliceosome function plays a key role in the …
-
Differential splicing and allelic imbalance as pathomechanisms of recurring mutations in Acute Myeloid Leukemia
… the identification of genes harboring recurrent mutations in this disease, and they are being used to inform clinical decisions. In the studies presented in this thesis the aim was to improve our understanding of these mutations to further refine clinical decision making. The first study provided …
-
R-loop accumulation induced by splicing perturbation triggers PARP1/2 response
… Recent studies showed that perturbing RNA splicing by pharmacological modulators selectively sensitizes RNA splicing mutant cancers in vitro and in vivo models. However, the use of pharmacological modulators in clinical trials did not show improved efficacy in patients carrying RNA splicing …
-
The conserved role of RNA splicing factors in genome maintenance
RNA splicing mutants have been broadly implicated in genome stability, but mechanistic links are often unclear. Two predominant models have emerged: one involving changes in gene expression that perturb other genome maintenance factors and another in which genotoxic DNA:RNA hybrids, called R-loops, …
-
IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF THE YEAST SPLICEOSOME
… thought to trigger active dissociation of faulty splicing complexes. A yeast genetic screen was performed to identify components of the putative discard pathway. This study found that weak mutant alleles of SPP382 suppress defects in several proteins required for spliceosome activation (Prp38p, …
-
Unravelling the molecular pathogenesis of Myelodysplastic Syndrome Patients with Ringed Sideroblasts
… of whom had >25% ringed sideroblasts identified mutations in one particular gene, splicing factor 3b subunit 1 (SF3B1), a component of the major and minor spliceosomes, in 11/12 cases. No SF3B1 mutations were observed in a single case of congenital sideroblastic anaemia, however, a constitutional …
-
Investigating the significance of alternative splicing in hematological malignancies
Somatic mutations in RNA splicing genes are frequent in many haematological malignancies, but are rarer in acute myeloid leukaemia (AML). However, their roles in leukaemogenesis are poorly described. To gain insights into the functional impact of alternative RNA splicing in leukemia, I investigated …
-
Identification of new therapeutic targets and drug repositioning in myelodysplastic syndromes using transcriptional profiling and connectivity mapping
… bone marrow CD34+ cells of MDS patients with splicing factor mutations or with advanced MDS (Refractory anaemia with excess blasts-2 subtype, RAEB-2 subtype). Compounds inducing a transcriptional response opposite to that of MDS cases were identified, which might be capable of reverting the …
-
INVESTIGATING THE EFFECT OF PRMT INHIBITORS ON MYELOID LEUKEMIAS WITH SPLICEOSOMAL GENE MUTATIONS
Mutations in RNA-splicing factors occur at high frequency in myelodysplastic syndromes and are also found in leukemias and solid cancers. The most commonly mutated splicing factors include SRSF2, SF3B1, U2AF1 and ZRSR2. These mutations occur in a heterozygous and mutually exclusive manner, …
-
Dissecting the role of CDK8 mis-splicing in SF3B1-mutant MDS
Somatic SF3B1 mutations are believed to arise early in the pathogenesis of clonal myeloid disorders such as myelodysplastic syndromes (MDS). Studies show that SF3B1 mutations bias hematopoietic stem and progenitor cells (HSPCs) toward the myeloid and erythroid lineages and impair terminal erythroid …